Status:
TERMINATED
Gene Expression In Pregnancies Complicated by Preeclampsia
Lead Sponsor:
University of Rochester
Conditions:
Preeclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to figure out some of the differences in bodily function between women who have preeclampsia and those who do not. * This may eventually lead to an understanding of its c...
Detailed Description
* Preeclampsia is a pregnancy-related disorder that occurs in about 6% of all pregnancies. * In its mild for, preeclampsia involves high blood pressure. More severe forms of preeclampsia can lead to m...
Eligibility Criteria
Inclusion
- Gravidas at 32-42 weeks gestation,who have preeclampsia as defined by Sibai et al, 1997.
- Control patients: Gravidas without history of hypertension of any kind, and matched to cases for parity, gestational age, labor status, maternal age, and race.
Exclusion
- Prior betamethasone administration, fetal growth restriction (\<3%ile), prior chronic hypertension (nonpregnant or \< 20 weeks gestation any pregnancy), chorioamnionitis, major fetal anomaly or chromosome abnormality, multiple gestation, and maternal diabetes (any class except diet-controlled gestational).
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT00919360
Start Date
June 1 2008
End Date
July 1 2015
Last Update
October 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642